Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when the Government plans announce its choice of British lateral flow test after the signing of contracts in March 2021 with Omega Diagnostics and Global Access Diagnostics in order to meet the target of having the majority of UK lateral flow tests produced in the UK.

The Government continues to explore different operating models to make best use of the capacity created in the United Kingdom diagnostics manufacturing industry. There are a number of ongoing conversations between Global Access Diagnostics, Omega and third party test developers which we hope will provide opportunities to further increase UK manufacturing output of lateral flow tests.